BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36720556)

  • 1. Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target.
    Zhang Y; Zhang L; Zhao Y; Wang S; Feng L
    Taiwan J Obstet Gynecol; 2023 Jan; 62(1):77-88. PubMed ID: 36720556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
    Zuo L; Li X; Tan Y; Zhu H; Xiao M
    J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients.
    Xiao C; Wang Y; Cheng Q; Fan Y
    Medicine (Baltimore); 2022 Aug; 101(34):e30279. PubMed ID: 36042626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
    Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
    Front Immunol; 2022; 13():943389. PubMed ID: 36003381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer.
    Xie B; Tan G; Ren J; Lu W; Pervaz S; Ren X; Otoo AA; Tang J; Li F; Wang Y; Wang M
    Front Oncol; 2022; 12():830908. PubMed ID: 35299734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
    Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
    J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDC80 Kinetochore Complex Serves as a Potential Prognostic Predictor and Correlates with Immune Infiltrates in Epithelial Ovarian Cancer Patients.
    Yu X; Pan M; Jiang L; Liu K
    Int J Gen Med; 2024; 17():1789-1805. PubMed ID: 38711823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient Prognosis.
    Lu X; Li R; Wang X; Guo Q; Wang L; Zhou X
    Cancer Biother Radiopharm; 2022 Nov; 37(9):850-861. PubMed ID: 34495766
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Autophagy-Related Genes on the Prognosis and Immune Microenvironment of Ovarian Cancer.
    Zhang J; Yan H; Fu Y
    Biomed Res Int; 2022; 2022():6609195. PubMed ID: 35941978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
    Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
    Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
    Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
    Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
    Front Genet; 2022; 13():1001239. PubMed ID: 36425071
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
    Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
    Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte Immunoglobulin-Like Receptors A2 and A6 are Expressed in Avian Macrophages and Modulate Cytokine Production by Activating Multiple Signaling Pathways.
    Truong AD; Rengaraj D; Hong Y; Tran HTT; Dang HV; Nguyen VK; Lillehoj HS; Hong YH
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer.
    Liu J; Xu F; Cheng W; Gao L
    Exp Cell Res; 2020 Oct; 395(2):112235. PubMed ID: 32805252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.